Biopharmaceutical
Cytokinetics is a specialty cardiovascular biopharmaceutical company with over 25 years of pioneering scientific innovations in muscle biology. The company is advancing a pipeline of potential new medicines designed for patients suffering from diseases of cardiac muscle dysfunction. Cytokinetics focuses on developing therapies that address critical unmet needs in the cardiovascular space by leveraging its deep expertise in muscle biology.
Beta · Sourced from candidate reports
Be the first to share your experience with Cytokinetics.
Your reply helps other candidates know what to expect.
